GlassScriptPhysician profile
Riley M Johnson
NPI 1366939779
$12,836.32
in general payments reported to CMS, 2019-2025
23 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.15 · 2021: $22.28 · 2022: $5,676 · 2023: $3,026 · 2024: $3,081 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,327 · Food and Beverage: $2,740 · Education: $52.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,326.56 |
| Food and Beverage | $2,740.29 |
| Education | $52.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,927.90 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Vanta Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $693.92 | 2023-2024 | Iovera, Exparel |
| Abbott Laboratories | $149.78 | 2023 | Proclaim |
| Boston Scientific Corporation | $130.14 | 2022 | |
| Genesys Orthopedics Systems, L.L.C. | $120.21 | 2025 | Sacroiliac Joint Fusion System |
| Merz Pharmaceuticals, LLC | $105.47 | 2023-2024 | Xeomin |
| Curonix LLC | $86.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Foundation Fusion Solutions, LLC | $81.45 | 2023-2025 | |
| Abbvie INC. | $79.61 | 2024-2025 | |
| Almatica Pharma LLC | $67.37 | 2021-2023 | Gralise |
| Saluda Medical Americas, INC. | $66.22 | 2025 | Evoke |
| Biotronik Nro, INC. | $59.22 | 2023-2025 | Biotronik, Prospera |
| Ethicon US, LLC | $52.78 | 2024 | Stratafix, Monocryl, Dermabond Prineo |
| Stratus Medical, LLC | $32.35 | 2023 | Nimbus |
| Painteq LLC | $30.85 | 2024 | Painteq |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $25.07 | 2025 | Monovisc |
| Pfizer INC. | $23.22 | 2025 | |
| Averitas Pharma INC. | $22.35 | 2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $21.83 | 2025 | |
| Avanos Medical | $20.02 | 2023 | Coolief* Cooled Radiofrequency |
| Medtronic USA, INC. | $18.15 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.71 | 2024 | Belbuca |
| Spr Therapeutics, INC | $6.70 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riley Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.